The discovery of TFA in blood and water samples raises questions about Chemours’ role in adding to the pollution burden.
Analyst/Investor Day December 4, 2025 12:00 PM ESTCompany ParticipantsMark Jafar - Global Head of Corporate CommunicationsRichard L.
Background CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patients with identical CFTR genotypes. This underscores the need for predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback